With this approval, Zydus has obtained 415 regulatory clearances and filed 483 Abbreviated New Drug Applications (ANDAs) as ...
Zydus Lifesciences share price will remain in focus on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.